SMS Lifesciences India Limited Capital Reinvestment Ratio

Latest as of March 2025: 0.45x

SMS Lifesciences India Limited capital reinvestment ratio. SMS Lifesciences India Limited (SMSLIFE) has a Capital Reinvestment Ratio of 0.45x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rs340.55 Million) in capital expenditures (Rs153.49 Million). Check SMSLIFE total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.45x
Capex / Operating Cash Flow

Operating Cash Flow

Rs340.55 Million
INR

Capital Expenditures

Rs153.49 Million
INR

Data as of

Mar 2025
Most recent filing

Capital Reinvestment Ratio of SMS Lifesciences India Limited (2016–2025)

Capital reinvestment ratio of SMS Lifesciences India Limited from 2016 to 2025. This chart tracks SMS Lifesciences India Limited's Capital Reinvestment Ratio across 9 annual periods. Also explore SMSLIFE shareholders equity momentum to track the company's year-over-year net asset growth rate.

SMS Lifesciences India Limited Capital Reinvestment Ratio by Year (2016–2025)

SMS Lifesciences India Limited capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see SMSLIFE cash generation efficiency.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 0.51x Rs298.10 Million Rs153.49 Million ▼ -40.0%
2024 0.86x Rs243.06 Million Rs208.68 Million ▼ -74.0%
2023 3.30x Rs1.47K Rs4.86K ▲ +226.8%
2021 1.01x Rs351.70 Million Rs355.56 Million ▼ -37.0%
2020 1.61x Rs145.47 Million Rs233.53 Million ▲ +97.2%
2019 0.81x Rs299.93 Million Rs244.18 Million ▲ +86.2%
2018 0.44x Rs80.00 Million Rs34.97 Million ▲ +17.3%
2017 0.37x Rs202.60 Million Rs75.50 Million ▼ -3.0%
2016 0.38x Rs196.59 Million Rs75.50 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow